The Role of Plant-Derived Quaternary Ammonium Compounds, Including Carnitine and Choline-O-Sulfate, on the Biology of the Plant

Total Page:16

File Type:pdf, Size:1020Kb

The Role of Plant-Derived Quaternary Ammonium Compounds, Including Carnitine and Choline-O-Sulfate, on the Biology of the Plant Iowa State University Capstones, Theses and Graduate Theses and Dissertations Dissertations 2015 The oler of plant-derived quaternary ammonium compounds, including carnitine and choline-O- sulfate, on the biology of the plant pathogen Pseudomonas syringae and its interactions with the host species Phaseolus vulgaris Michael David Millican Iowa State University Follow this and additional works at: https://lib.dr.iastate.edu/etd Part of the Agriculture Commons, Microbiology Commons, and the Plant Pathology Commons Recommended Citation Millican, Michael David, "The or le of plant-derived quaternary ammonium compounds, including carnitine and choline-O-sulfate, on the biology of the plant pathogen Pseudomonas syringae and its interactions with the host species Phaseolus vulgaris" (2015). Graduate Theses and Dissertations. 14948. https://lib.dr.iastate.edu/etd/14948 This Dissertation is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University Digital Repository. It has been accepted for inclusion in Graduate Theses and Dissertations by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. The role of plant-derived quaternary ammonium compounds, including carnitine and choline-O-sulfate, on the biology of the plant pathogen Pseudomonas syringae and its interactions with the host species Phaseolus vulgaris by Michael D. Millican A dissertation submitted to the graduate faculty in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY Major: Microbiology Program of Study Committee: Gwyn Beattie, Major Professor Thomas Bobik Qijing Zhang Byron Brehm-Stecher Larry Halverson Iowa State University Ames, Iowa 2015 Copyright © Michael D. Millican, 2015. All rights reserved. ii DEDICATION To my parents, Doug and Mary Millican. You have selflessly provided me the opportunity to pursue my dreams and no words could express my admiration and appreciation for you and all that you have done for me. And to my wife, Sarani Rangarajan, for your unwavering support I would like to thank you from the bottom of my heart, but for you my heart has no bottom. iii TABLE OF CONTENTS Page ACKNOWLEDGMENTS ........................................................................................ v ABSTRACT………………………………. ............................................................. vi CHAPTER 1 GENERAL INTRODUCTION ...................................................... 1 Introduction ........................................................................................................ 1 Thesis Organization ............................................................................................ 2 Literature Review ................................................................................................ 3 References ........................................................................................................ 13 CHAPTER 2 CARNITINE RELEASED FROM GERMINATING PHASEOLUS VULGARIS SEEDS PROMOTES THE GROWTH OF PSEUDOMONAS SYRINGAE AND REQUIRES DHCAB FOR REMOVAL OF THE INTERMEDIATE ACETOACETATE FOR CATABOLISM .................. 26 Abstract to ........................................................................................................ 26 Introduction ........................................................................................................ 27 Methods and Materials ....................................................................................... 30 Results of the ....................................................................................................... 37 Discussion ........................................................................................................ 50 References ........................................................................................................ 55 CHAPTER 3 CHOLINE-O-SULFATE CATABOLISM IN PSEUDOMONAS SYRINGAE REQUIRES A SULFATE EXPORTER THAT MAY FUNCTION TO RELIEVE SULFATE TOXICITY AND IS ENCODED IN A LOCUS WITH CHOLINE-O-SULFATE SULFATASE ..................................................................... 60 Abstract to ........................................................................................................ 60 Introduction ........................................................................................................ 61 Methods and Materials ....................................................................................... 64 Results of the ....................................................................................................... 66 Discussion ........................................................................................................ 75 References ........................................................................................................ 84 iv CHAPTER 4 PLANT TISSUE-SPECIFIC BENEFITS OF QUATERNARY AMMONIUM COMPOUNDS TO PSEUDOMONAS SYRINGAE DURING LEAF AND SEED COLONIZATION ..................................................................... 89 Abstract to ........................................................................................................ 89 Introduction ........................................................................................................ 90 Methods and Materials ....................................................................................... 95 Results of the ....................................................................................................... 98 Discussion ........................................................................................................ 105 References ........................................................................................................ 113 CHAPTER 5 CONCLUSIONS AND FUTURE DIRECTIONS ......................... 118 References ........................................................................................................... 121 APPENDIX A SUPPLEMENTARY TABLES AND FIGURES FOR CHAPTER II ........................................................................................................... 123 APPENDIX B SUPPLEMENTARY TABLES AND FIGURES FOR CHAPTER III ........................................................................................................... 131 APPENDIX C SUPPLEMENTARY FIGURES FOR CHAPTER IV .................. 140 v ACKNOWLEDGMENTS I would like to thank my advisor, Gwyn A. Beattie, for her endless patience and thoughtful guidance over these years. I would also like to thank my committee members, Thomas Bobik, Qijing Zhang, Byron Brehm-Stecher, and Larry Halverson for their guidance and support throughout the course of this research. In addition, I would also like to thank my wife, without whom this dissertation would be an jarrbelled un reedabel dizazter. I want to thank my friends and family who have supported me all these years. Lastly, but certainly not least, I would like to thank Regina McGrane for her thoughtful input and countless discussions. vi ABSTRACT Knowledge of the chemicals available during plant-microbe interactions is useful for promoting the growth of beneficial bacteria and predicting pathogen populations and thus the probability of disease. Pseudomonas syringae B728a is able to utilize plant-derived quaternary ammonium compounds (QACs), such as L-carnitine, choline, and choline derivatives, as osmoprotectants and nutrient sources. We explored in detail the biological roles of carnitine and choline-O-sulfate in P. syringae cells, including in culture and during host colonization. Although genes involved in carnitine catabolism were identified in other organisms, the roles of these genes have not been fully elucidated. We analyzed conflicting reports of the carnitine to glycine betaine degradation pathway and provided evidence for a modified pathway based on the growth and accumulation of metabolic intermediates in catabolic mutants. Although carnitine is converted to glycine betaine for accumulation as a compatible solute in B728a, we found that carnitine itself can function as a compatible solute in P. syringae. This was based on both the ability of a carnitine catabolic mutant to derive osmoprotection from carnitine, and the accumulation of carnitine in this mutant as detected using MALDI-MSI. Although we did not detect evidence for carnitine production by bean leaves, we discovered that carnitine is released during bean seed germination, specifically during radicle emergence and elongation, and this carnitine strongly contributed to the growth of B728a on germinating seeds. In exploring the genes involved in the catabolism of choline-O-sulfate (COS), we confirmed that a predicted COS sulfatase was required for catabolizing COS as a nutrient and osmoprotectant, but did not impact P. vulgaris leaf or vii seed colonization, indicating little to no available COS in bean plants. However, we found unexpected evidence that a sulfate exporter is critical to the use of COS as a nutrient or osmoprotectant; this supports a model in which this exporter removes sulfate released from the cleavage of COS and prevents accumulation to toxic levels. Although COS was not a significant source of sulfur during colonization of the plant host, we used transcriptome data to elaborate a likely metabolic network highlighting multiple organosulfur sources that supply leaf surface bacteria with sulfur. Lastly, we systematically evaluated the roles of a broad set of QACs, including choline, phosphorylcholine,
Recommended publications
  • (10) Patent No.: US 8119385 B2
    US008119385B2 (12) United States Patent (10) Patent No.: US 8,119,385 B2 Mathur et al. (45) Date of Patent: Feb. 21, 2012 (54) NUCLEICACIDS AND PROTEINS AND (52) U.S. Cl. ........................................ 435/212:530/350 METHODS FOR MAKING AND USING THEMI (58) Field of Classification Search ........................ None (75) Inventors: Eric J. Mathur, San Diego, CA (US); See application file for complete search history. Cathy Chang, San Diego, CA (US) (56) References Cited (73) Assignee: BP Corporation North America Inc., Houston, TX (US) OTHER PUBLICATIONS c Mount, Bioinformatics, Cold Spring Harbor Press, Cold Spring Har (*) Notice: Subject to any disclaimer, the term of this bor New York, 2001, pp. 382-393.* patent is extended or adjusted under 35 Spencer et al., “Whole-Genome Sequence Variation among Multiple U.S.C. 154(b) by 689 days. Isolates of Pseudomonas aeruginosa” J. Bacteriol. (2003) 185: 1316 1325. (21) Appl. No.: 11/817,403 Database Sequence GenBank Accession No. BZ569932 Dec. 17. 1-1. 2002. (22) PCT Fled: Mar. 3, 2006 Omiecinski et al., “Epoxide Hydrolase-Polymorphism and role in (86). PCT No.: PCT/US2OO6/OOT642 toxicology” Toxicol. Lett. (2000) 1.12: 365-370. S371 (c)(1), * cited by examiner (2), (4) Date: May 7, 2008 Primary Examiner — James Martinell (87) PCT Pub. No.: WO2006/096527 (74) Attorney, Agent, or Firm — Kalim S. Fuzail PCT Pub. Date: Sep. 14, 2006 (57) ABSTRACT (65) Prior Publication Data The invention provides polypeptides, including enzymes, structural proteins and binding proteins, polynucleotides US 201O/OO11456A1 Jan. 14, 2010 encoding these polypeptides, and methods of making and using these polynucleotides and polypeptides.
    [Show full text]
  • Orphan Enzymes Could Be an Unexplored Reservoir of New Drug Targets
    Drug Discovery Today Volume 11, Numbers 7/8 April 2006 REVIEWS Reviews GENE TO SCREEN Orphan enzymes could be an unexplored reservoir of new drug targets Olivier Lespinet and Bernard Labedan Institut de Ge´ne´tique et Microbiologie, CNRS UMR 8621, Universite´ Paris Sud, Baˆtiment 400, 91405 Orsay Cedex, France Despite the immense progress of genomics, and the current availability of several hundreds of thousands of amino acid sequences, >39% of well-defined enzyme activities (as represented by enzyme commission, EC, numbers) are not associated with any sequence. There is an urgent need to explore the 1525 orphan enzymes (enzymes having EC numbers without an associated sequence) to bridge the wide gap that separates knowledge of biochemical function and sequence information. Strikingly, orphan enzymes can even be found among enzymatic activities successfully used as drug targets. Here, knowledge of sequence would help to develop molecular-targeted therapies, suppressing many drug-related side-effects. Biology is exploring numerous and diverse fields, each of which discovered before, despite intensive research by thousands of is very complex and difficult to study in its entirety. For many people studying the genetics and biochemistry of Saccharomyces years, immense advances in disclosing molecular functions have cerevisiae over the past 50 years. This observation has been con- been made using reductionist approaches, such as molecular firmed repeatedly, with the cohort of genomes that have been biology. Combining genetic, biophysical and biochemical con- sequenced, at a steady pace, over the past ten years. We now know cepts and methodologies has helped to disclose details of com- that many genes have been missed by reductionist approaches plex molecular mechanisms such as DNA replication.
    [Show full text]
  • Phosphoethanolamine N-Methyl Transferase From
    PHOSPHOETHANOLAMINE N-METHYLTRANSFERASE FROM SPINACH PURIFICATION AND CHARACTERIZATION OF 5-ADENOSYL-L-METHIONINE: PHOSPHOETHANOLAMINE N-METHYLTRANSFERASE FROM SPINACH by DAVID DELMAR SMITH, B.Sc. A Thesis Submitted to the School of Graduate Studies in Partial Fulfilment of the Requirements for the Degree Masters of Science McMaster University (c) Copyright by David Delmar Smith, September 1995 Descriptive Note Masters of Science (1995) McMaster University Biology Hamilton, Ontario TITLE: Purification and Characterization of S-Adenosyi-L-Methionine: Phosphoethanolamine N-Methyltransferase From Spinach AUTHOR: David Delmar Smith, B.Sc. (McMaster University) SUPERVISOR: Dr. Elizabeth A. Weretilnyk NUMBER OF PAGES: xvi, 136 ii ABSTRACT During conditions of osmotic stress, some plants accumulate compatible osmolytes such as glycine betaine or choline-0-sulphate. Choline is required as a precursor for synthesis of both osmolytes and choline is also required by all plants as a component of phospholipids. In the betaine accumulator spinach, choline synthesis requires three sequential N-methylations of phosphoethanolamine (PEA) to generate phosphocholine (PCho), with the first N-methylation being catalyzed by S-adenosyi-L-methionine: PEA N­ methyltransferase (PEAMeT). Choline synthesis and, more particularly the activity of PEAMeT, are up-regulated by salinity (Summers and Weretilnyk, 1993). This thesis reports on the partial purification and preliminary characterization of PEAMeT from spinach. A variety of column chromatography matrices including DEAE Sepharose, phenyl Sepharose, w-aminohexyl agarose, hydroxylapatite, phenyl Superose, Mono Q and adenosine agarose, have been used to purify PEAMeT. A 5403- 1 1 fold purified preparation yielded a specific activity of 189 nmol· min- • mg- protein. SDS-PAGE analysis of this preparation revealed a number of polypeptide bands but only one which photoaffinity cross-linked to [3 H]SAM.
    [Show full text]
  • Der Jasmonsäure-Metabolismus in Tomate (Solanum Lycopersicum
    Literaturverzeichnis 6 Literaturverzeichnis 141 Literaturverzeichnis Afitlhile, M. M.; Fukushige, H.; Nishimura, M.; Hildebrand, D. F. (2005): A defect in glyoxysomal fatty acid ß-oxidation reduces jasmonic acid accumulation in Arabidopsis. Plant Physiology and Biochemistry 43: 603-609. Ahn, J. A.; Miller, D.; Winter, V. J.; Banfield, M. J.; Lee, J. H.; Yoo, S. Y.; Henz, S. R.; Brady, R. L.; Wei- gel, D. (2006): A divergent external loop confers antagonistic activity on floral regulators FT and TFL1. EMBO Journal 25: 605–614. Allen, K. D.; Sussex, I. M. (1996): Falsiflora and anantha control early stages of floral meristem develop- ment in tomato (Lycopersicon esculentum Mill). Planta 200: 254–264. Ananvoranich, S.; Varin, L.; Gulick, P.; Ibrahim, R. K. (1994) Cloning and regulation of flavonol 3-sul- fotransferasein cell suspension cultures of Flaveria bidentis. Plant Physiol. 106: 485-491. Andersson, M. X.; Hamberg, M.; Kourtchenko, O.; Brunnstrom, A.; McPhail, K. L.; Gerwick, W. H.; Gobel, C., Feussner, I.; Ellerstrom, M. (2006): Oxylipin profiling of the hypersensitive response in Arabidopsis thaliana: formation of a novel oxo-phytodienoic acid-containing galactolipid, Arabidopside E. Journal of Biological Chemistry 281: 31528-31537. Atherton, J. G.; Harris, J. (1986): The tomato crop. London: Chapman and Hall. Barron, D.; Varin, L.; Ibrahim, R. K.; Harborne, J. B.; Williams, C. A. (1988): Sulphated flavonoids – an update. Phytochemistry 27: 2375-2395. Bäurle, I.; Dean, C. (2006): The timing of developmental transitions in plants. Cell 125: 655-664. Bell, P. R. (1992): Green plants: their origin and diversity. Cambridge: Cambridge University Press. Bergey, D. R.; Howe, G. A.; Ryan, C.
    [Show full text]
  • Structural and Biochemical Studies of Sulphotransferase 18 From
    Structural and biochemical studies of sulphotransferase 18 from Arabidopsis thaliana explain its substrate specificity and reaction mechanism Hirschmann, Felix; Krause, Florian; Baruch, Petra; Chizhov, Igor; Mueller, Jonathan Wolf; Manstein, Dietmar J; Papenbrock, Jutta; Fedorov, Roman DOI: 10.1038/s41598-017-04539-2 License: Creative Commons: Attribution (CC BY) Document Version Publisher's PDF, also known as Version of record Citation for published version (Harvard): Hirschmann, F, Krause, F, Baruch, P, Chizhov, I, Mueller, JW, Manstein, DJ, Papenbrock, J & Fedorov, R 2017, 'Structural and biochemical studies of sulphotransferase 18 from Arabidopsis thaliana explain its substrate specificity and reaction mechanism', Scientific Reports, vol. 7, 4160. https://doi.org/10.1038/s41598-017-04539- 2 Link to publication on Research at Birmingham portal General rights Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes permitted by law. •Users may freely distribute the URL that is used to identify this publication. •Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private study or non-commercial research. •User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?) •Users may not further distribute the material nor use it for the purposes of commercial gain. Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2012/0266329 A1 Mathur Et Al
    US 2012026.6329A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2012/0266329 A1 Mathur et al. (43) Pub. Date: Oct. 18, 2012 (54) NUCLEICACIDS AND PROTEINS AND CI2N 9/10 (2006.01) METHODS FOR MAKING AND USING THEMI CI2N 9/24 (2006.01) CI2N 9/02 (2006.01) (75) Inventors: Eric J. Mathur, Carlsbad, CA CI2N 9/06 (2006.01) (US); Cathy Chang, San Marcos, CI2P 2L/02 (2006.01) CA (US) CI2O I/04 (2006.01) CI2N 9/96 (2006.01) (73) Assignee: BP Corporation North America CI2N 5/82 (2006.01) Inc., Houston, TX (US) CI2N 15/53 (2006.01) CI2N IS/54 (2006.01) CI2N 15/57 2006.O1 (22) Filed: Feb. 20, 2012 CI2N IS/60 308: Related U.S. Application Data EN f :08: (62) Division of application No. 1 1/817,403, filed on May AOIH 5/00 (2006.01) 7, 2008, now Pat. No. 8,119,385, filed as application AOIH 5/10 (2006.01) No. PCT/US2006/007642 on Mar. 3, 2006. C07K I4/00 (2006.01) CI2N IS/II (2006.01) (60) Provisional application No. 60/658,984, filed on Mar. AOIH I/06 (2006.01) 4, 2005. CI2N 15/63 (2006.01) Publication Classification (52) U.S. Cl. ................... 800/293; 435/320.1; 435/252.3: 435/325; 435/254.11: 435/254.2:435/348; (51) Int. Cl. 435/419; 435/195; 435/196; 435/198: 435/233; CI2N 15/52 (2006.01) 435/201:435/232; 435/208; 435/227; 435/193; CI2N 15/85 (2006.01) 435/200; 435/189: 435/191: 435/69.1; 435/34; CI2N 5/86 (2006.01) 435/188:536/23.2; 435/468; 800/298; 800/320; CI2N 15/867 (2006.01) 800/317.2: 800/317.4: 800/320.3: 800/306; CI2N 5/864 (2006.01) 800/312 800/320.2: 800/317.3; 800/322; CI2N 5/8 (2006.01) 800/320.1; 530/350, 536/23.1: 800/278; 800/294 CI2N I/2 (2006.01) CI2N 5/10 (2006.01) (57) ABSTRACT CI2N L/15 (2006.01) CI2N I/19 (2006.01) The invention provides polypeptides, including enzymes, CI2N 9/14 (2006.01) structural proteins and binding proteins, polynucleotides CI2N 9/16 (2006.01) encoding these polypeptides, and methods of making and CI2N 9/20 (2006.01) using these polynucleotides and polypeptides.
    [Show full text]
  • All Enzymes in BRENDA™ the Comprehensive Enzyme Information System
    All enzymes in BRENDA™ The Comprehensive Enzyme Information System http://www.brenda-enzymes.org/index.php4?page=information/all_enzymes.php4 1.1.1.1 alcohol dehydrogenase 1.1.1.B1 D-arabitol-phosphate dehydrogenase 1.1.1.2 alcohol dehydrogenase (NADP+) 1.1.1.B3 (S)-specific secondary alcohol dehydrogenase 1.1.1.3 homoserine dehydrogenase 1.1.1.B4 (R)-specific secondary alcohol dehydrogenase 1.1.1.4 (R,R)-butanediol dehydrogenase 1.1.1.5 acetoin dehydrogenase 1.1.1.B5 NADP-retinol dehydrogenase 1.1.1.6 glycerol dehydrogenase 1.1.1.7 propanediol-phosphate dehydrogenase 1.1.1.8 glycerol-3-phosphate dehydrogenase (NAD+) 1.1.1.9 D-xylulose reductase 1.1.1.10 L-xylulose reductase 1.1.1.11 D-arabinitol 4-dehydrogenase 1.1.1.12 L-arabinitol 4-dehydrogenase 1.1.1.13 L-arabinitol 2-dehydrogenase 1.1.1.14 L-iditol 2-dehydrogenase 1.1.1.15 D-iditol 2-dehydrogenase 1.1.1.16 galactitol 2-dehydrogenase 1.1.1.17 mannitol-1-phosphate 5-dehydrogenase 1.1.1.18 inositol 2-dehydrogenase 1.1.1.19 glucuronate reductase 1.1.1.20 glucuronolactone reductase 1.1.1.21 aldehyde reductase 1.1.1.22 UDP-glucose 6-dehydrogenase 1.1.1.23 histidinol dehydrogenase 1.1.1.24 quinate dehydrogenase 1.1.1.25 shikimate dehydrogenase 1.1.1.26 glyoxylate reductase 1.1.1.27 L-lactate dehydrogenase 1.1.1.28 D-lactate dehydrogenase 1.1.1.29 glycerate dehydrogenase 1.1.1.30 3-hydroxybutyrate dehydrogenase 1.1.1.31 3-hydroxyisobutyrate dehydrogenase 1.1.1.32 mevaldate reductase 1.1.1.33 mevaldate reductase (NADPH) 1.1.1.34 hydroxymethylglutaryl-CoA reductase (NADPH) 1.1.1.35 3-hydroxyacyl-CoA
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2015/0240226A1 Mathur Et Al
    US 20150240226A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2015/0240226A1 Mathur et al. (43) Pub. Date: Aug. 27, 2015 (54) NUCLEICACIDS AND PROTEINS AND CI2N 9/16 (2006.01) METHODS FOR MAKING AND USING THEMI CI2N 9/02 (2006.01) CI2N 9/78 (2006.01) (71) Applicant: BP Corporation North America Inc., CI2N 9/12 (2006.01) Naperville, IL (US) CI2N 9/24 (2006.01) CI2O 1/02 (2006.01) (72) Inventors: Eric J. Mathur, San Diego, CA (US); CI2N 9/42 (2006.01) Cathy Chang, San Marcos, CA (US) (52) U.S. Cl. CPC. CI2N 9/88 (2013.01); C12O 1/02 (2013.01); (21) Appl. No.: 14/630,006 CI2O I/04 (2013.01): CI2N 9/80 (2013.01); CI2N 9/241.1 (2013.01); C12N 9/0065 (22) Filed: Feb. 24, 2015 (2013.01); C12N 9/2437 (2013.01); C12N 9/14 Related U.S. Application Data (2013.01); C12N 9/16 (2013.01); C12N 9/0061 (2013.01); C12N 9/78 (2013.01); C12N 9/0071 (62) Division of application No. 13/400,365, filed on Feb. (2013.01); C12N 9/1241 (2013.01): CI2N 20, 2012, now Pat. No. 8,962,800, which is a division 9/2482 (2013.01); C07K 2/00 (2013.01); C12Y of application No. 1 1/817,403, filed on May 7, 2008, 305/01004 (2013.01); C12Y 1 1 1/01016 now Pat. No. 8,119,385, filed as application No. PCT/ (2013.01); C12Y302/01004 (2013.01); C12Y US2006/007642 on Mar. 3, 2006.
    [Show full text]
  • Structural and Biochemical Studies of Sulphotransferase 18 From
    University of Birmingham Structural and biochemical studies of sulphotransferase 18 from Arabidopsis thaliana explain its substrate specificity and reaction mechanism Hirschmann, Felix; Krause, Florian; Baruch, Petra; Chizhov, Igor; Mueller, Jonathan Wolf; Manstein, Dietmar J; Papenbrock, Jutta; Fedorov, Roman DOI: 10.1038/s41598-017-04539-2 License: Creative Commons: Attribution (CC BY) Document Version Publisher's PDF, also known as Version of record Citation for published version (Harvard): Hirschmann, F, Krause, F, Baruch, P, Chizhov, I, Mueller, JW, Manstein, DJ, Papenbrock, J & Fedorov, R 2017, 'Structural and biochemical studies of sulphotransferase 18 from Arabidopsis thaliana explain its substrate specificity and reaction mechanism', Scientific Reports, vol. 7, 4160. https://doi.org/10.1038/s41598-017-04539- 2 Link to publication on Research at Birmingham portal General rights Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes permitted by law. •Users may freely distribute the URL that is used to identify this publication. •Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private study or non-commercial research. •User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?) •Users may not further distribute the material nor use it for the purposes of commercial gain. Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
    [Show full text]
  • Single-Cell Genomics Reveals Complex Carbohydrate Degradation Patterns in Poribacterial Symbionts of Marine Sponges
    The ISME Journal (2013) 7, 2287–2300 & 2013 International Society for Microbial Ecology All rights reserved 1751-7362/13 www.nature.com/ismej ORIGINAL ARTICLE Single-cell genomics reveals complex carbohydrate degradation patterns in poribacterial symbionts of marine sponges Janine Kamke1, Alexander Sczyrba2,3, Natalia Ivanova2, Patrick Schwientek2, Christian Rinke2, Kostas Mavromatis2, Tanja Woyke2 and Ute Hentschel1 1Department of Botany II, Julius-von-Sachs Institute for Biological Sciences, University of Wuerzburg, Wuerzburg, Germany; 2Department of Energy Joint Genome Institute, Walnut Creek, CA, USA and 3Center for Biotechnology, Bielefeld University, Bielefeld, Germany Many marine sponges are hosts to dense and phylogenetically diverse microbial communities that are located in the extracellular matrix of the animal. The candidate phylum Poribacteria is a predominant member of the sponge microbiome and its representatives are nearly exclusively found in sponges. Here we used single-cell genomics to obtain comprehensive insights into the metabolic potential of individual poribacterial cells representing three distinct phylogenetic groups within Poribacteria. Genome sizes were up to 5.4 Mbp and genome coverage was as high as 98.5%. Common features of the poribacterial genomes indicated that heterotrophy is likely to be of importance for this bacterial candidate phylum. Carbohydrate-active enzyme database screening and further detailed analysis of carbohydrate metabolism suggested the ability to degrade diverse carbohydrate sources likely originating from seawater and from the host itself. The presence of uronic acid degradation pathways as well as several specific sulfatases provides strong support that Poribacteria degrade glycosaminoglycan chains of proteoglycans, which are important components of the sponge host matrix. Dominant glycoside hydrolase families further suggest degradation of other glycoproteins in the host matrix.
    [Show full text]
  • Supplementary Material (ESI) for Natural Product Reports
    Electronic Supplementary Material (ESI) for Natural Product Reports. This journal is © The Royal Society of Chemistry 2014 Supplement to the paper of Alexey A. Lagunin, Rajesh K. Goel, Dinesh Y. Gawande, Priynka Pahwa, Tatyana A. Gloriozova, Alexander V. Dmitriev, Sergey M. Ivanov, Anastassia V. Rudik, Varvara I. Konova, Pavel V. Pogodin, Dmitry S. Druzhilovsky and Vladimir V. Poroikov “Chemo- and bioinformatics resources for in silico drug discovery from medicinal plants beyond their traditional use: a critical review” Contents PASS (Prediction of Activity Spectra for Substances) Approach S-1 Table S1. The lists of 122 known therapeutic effects for 50 analyzed medicinal plants with accuracy of PASS prediction calculated by a leave-one-out cross-validation procedure during the training and number of active compounds in PASS training set S-6 Table S2. The lists of 3,345 mechanisms of action that were predicted by PASS and were used in this study with accuracy of PASS prediction calculated by a leave-one-out cross-validation procedure during the training and number of active compounds in PASS training set S-9 Table S3. Comparison of direct PASS prediction results of known effects for phytoconstituents of 50 TIM plants with prediction of known effects through “mechanism-effect” and “target-pathway- effect” relationships from PharmaExpert S-79 S-1 PASS (Prediction of Activity Spectra for Substances) Approach PASS provides simultaneous predictions of many types of biological activity (activity spectrum) based on the structure of drug-like compounds. The approach used in PASS is based on the suggestion that biological activity of any drug-like compound is a function of its structure.
    [Show full text]
  • Springer Handbook of Enzymes
    Dietmar Schomburg Ida Schomburg (Eds.) Springer Handbook of Enzymes Alphabetical Name Index 1 23 © Springer-Verlag Berlin Heidelberg New York 2010 This work is subject to copyright. All rights reserved, whether in whole or part of the material con- cerned, specifically the right of translation, printing and reprinting, reproduction and storage in data- bases. The publisher cannot assume any legal responsibility for given data. Commercial distribution is only permitted with the publishers written consent. Springer Handbook of Enzymes, Vols. 1–39 + Supplements 1–7, Name Index 2.4.1.60 abequosyltransferase, Vol. 31, p. 468 2.7.1.157 N-acetylgalactosamine kinase, Vol. S2, p. 268 4.2.3.18 abietadiene synthase, Vol. S7,p.276 3.1.6.12 N-acetylgalactosamine-4-sulfatase, Vol. 11, p. 300 1.14.13.93 (+)-abscisic acid 8’-hydroxylase, Vol. S1, p. 602 3.1.6.4 N-acetylgalactosamine-6-sulfatase, Vol. 11, p. 267 1.2.3.14 abscisic-aldehyde oxidase, Vol. S1, p. 176 3.2.1.49 a-N-acetylgalactosaminidase, Vol. 13,p.10 1.2.1.10 acetaldehyde dehydrogenase (acetylating), Vol. 20, 3.2.1.53 b-N-acetylgalactosaminidase, Vol. 13,p.91 p. 115 2.4.99.3 a-N-acetylgalactosaminide a-2,6-sialyltransferase, 3.5.1.63 4-acetamidobutyrate deacetylase, Vol. 14,p.528 Vol. 33,p.335 3.5.1.51 4-acetamidobutyryl-CoA deacetylase, Vol. 14, 2.4.1.147 acetylgalactosaminyl-O-glycosyl-glycoprotein b- p. 482 1,3-N-acetylglucosaminyltransferase, Vol. 32, 3.5.1.29 2-(acetamidomethylene)succinate hydrolase, p. 287 Vol.
    [Show full text]